Summit Trail Advisors LLC purchased a new stake in Fabrinet (NYSE:FN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 848 shares of the technology company’s stock, valued at approximately $208,000.
Several other large investors have also added to or reduced their stakes in the business. Evoke Wealth LLC purchased a new stake in Fabrinet in the 4th quarter valued at about $3,135,000. Cim LLC purchased a new stake in Fabrinet in the 4th quarter valued at about $1,194,000. Norden Group LLC increased its stake in Fabrinet by 1,775.2% in the 1st quarter. Norden Group LLC now owns 28,616 shares of the technology company’s stock valued at $5,409,000 after buying an additional 27,090 shares during the last quarter. Pitcairn Co. purchased a new stake in shares of Fabrinet during the 1st quarter worth approximately $544,000. Finally, Franklin Resources Inc. purchased a new stake in shares of Fabrinet during the 4th quarter worth approximately $1,421,000. Institutional investors own 97.38% of the company’s stock.
Insider Buying and Selling
In related news, EVP Edward T. Archer sold 8,690 shares of Fabrinet stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $220.26, for a total value of $1,914,059.40. Following the transaction, the executive vice president now owns 8,333 shares in the company, valued at approximately $1,835,426.58. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CFO Csaba Sverha sold 9,288 shares of Fabrinet stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $270.08, for a total value of $2,508,503.04. Following the transaction, the chief financial officer now owns 19,768 shares in the company, valued at approximately $5,338,941.44. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Edward T. Archer sold 8,690 shares of Fabrinet stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $220.26, for a total transaction of $1,914,059.40. Following the completion of the transaction, the executive vice president now owns 8,333 shares in the company, valued at approximately $1,835,426.58. The disclosure for this sale can be found here. Insiders have sold a total of 44,728 shares of company stock worth $11,645,062 in the last 90 days. 0.51% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on FN
Fabrinet Stock Performance
NYSE FN opened at $230.96 on Wednesday. Fabrinet has a 52-week low of $149.19 and a 52-week high of $278.38. The company has a market capitalization of $8.35 billion, a P/E ratio of 30.67 and a beta of 0.96. The company has a fifty day moving average of $228.13 and a 200-day moving average of $219.41.
Fabrinet (NYSE:FN – Get Free Report) last posted its quarterly earnings data on Monday, August 19th. The technology company reported $2.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.06 by $0.35. The company had revenue of $753.26 million during the quarter, compared to the consensus estimate of $732.63 million. Fabrinet had a net margin of 10.27% and a return on equity of 18.10%. The firm’s revenue was up 14.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.68 EPS. As a group, analysts forecast that Fabrinet will post 9.11 EPS for the current fiscal year.
Fabrinet Company Profile
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
Featured Stories
- Five stocks we like better than Fabrinet
- What does consumer price index measure?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is the Dow Jones Industrial Average (DJIA)?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet (NYSE:FN – Free Report).
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.